RxDoctor Payments Data

Lourdes Pahuriray

Nurse Practitioner · Las Vegas, NVNPI 1801905575

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,717 of the $7,535 with a category attached, or 89.1%. 19 manufacturers reported payments, led by AstraZeneca at 27.3% of the total. Among nurse practitioner clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,535in general payments, 2019–2025

Across 243 payments — averaging $31.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Novo Nordisk$2K
  • Biohaven Pharmaceuticals, Inc.$853
  • AbbVie$565
  • Bayer$412
  • GSK$386
  • plus $2K from 13 others

What the payments were for

  • Consulting fees$80011%
  • Travel & lodging$180%
  • Food & beverage$6,71789%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,535 in reported general payments places this provider in the 95th percentile of 933 nurse practitioner providers in Nevada.

See all nurse practitioner providers in Nevada

Other nurse practitioner in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →